Home
>
National Drug Code (NDC)
>
INVANZ
INVANZ - 0006-3845-71 - (ertapenem sodium)
Drug Information of INVANZ
| Product NDC: | 0006-3845 |
| Proprietary Name: | INVANZ |
| Non Proprietary Name: | ertapenem sodium |
| Active Ingredient(s): | 1 g/1 & nbsp; ertapenem sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of INVANZ
| Product NDC: | 0006-3845 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021337 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20011121 |
Package Information of INVANZ
| Package NDC: | 0006-3845-71 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 TRAY (0006-3845-71) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0006-3845-01) |
NDC Information of INVANZ
| NDC Code | 0006-3845-71 |
| Proprietary Name | INVANZ |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 TRAY (0006-3845-71) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0006-3845-01) |
| Product NDC | 0006-3845 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ertapenem sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20011121 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | ERTAPENEM SODIUM |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] |
